Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Advertising
Top Story
People on the Move
Illumina elects new independent members to its board
Stephen MacMillan, chair, president, and CEO of Hologic, will be an independent director and non-executive chair. Scott Ullem, chief financial officer of Edwards Life Sciences, will be an independent director and a member of the Audit Committee.
Featured
Liquid Biopsy
Labcorp launches liquid biopsy test for oncology
Sequencing
Deep sequencing captures genetic variants for vascular anomalies
Latest News
Invivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detection
June 2, 2023
Sponsored
Visit our Molecular Diagnostics Community
May 11, 2023
Advocacy groups in letter urge FDA to develop regulations for lab-developed tests
June 1, 2023
Nucleai, Adlai Nortye collaborate on biomarkers for clinical trials
May 31, 2023
Stay in the Know
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Sign Up
Business Insights
Regulatory Approval
Seegene obtains IVDR certification for 30 diagnostic assays
Policy and Regulation
Advocacy groups in letter urge FDA to develop regulations for lab-developed tests
Collaboration
Nucleai, Adlai Nortye collaborate on biomarkers for clinical trials
Kickback
Georgia doctor, clinics to pay $625K to resolve False Claims Act allegations
Diagnostic Technologies
Liquid Biopsy
Labcorp launches liquid biopsy test for oncology
Collaboration
Nucleai, Adlai Nortye collaborate on biomarkers for clinical trials
Neurodegenerative Disease
Serum assay may enable the diagnosis of neurodegenerative diseases
Business Insights
Romanian IVD market worth watching, rose to $464M in 2022
Diseases
COVID-19
Long COVID symptoms reported by 17% of unvaccinated people
Sequencing
Deep sequencing captures genetic variants for vascular anomalies
Cardiovascular
One-third of U.S. adults with diabetes may have undetected cardiovascular disease
COVID-19
COVID-19’s 'long tail' analyzed at European rheumatology congress
More from LabPulse.com
Long COVID symptoms reported by 17% of unvaccinated people
One in six unvaccinated people report persistent health impacts from COVID-19 two years after a confirmed SARS-CoV-2 infection.
June 1, 2023
One-third of U.S. adults with diabetes may have undetected cardiovascular disease
Researchers at Johns Hopkins University have generated evidence of how prevalent elevated levels of two biomarkers are in U.S. adults, with and without diabetes.
June 1, 2023
COVID-19’s 'long tail' analyzed at European rheumatology congress
EULAR’s 2023 Congress includes presentations on iRD patients’ susceptibility to long COVID, and COVID-19 vaccination safety in pregnant and breastfeeding women with autoimmune disease.
May 31, 2023
Serum assay may enable the diagnosis of neurodegenerative diseases
An assay that detects minute concentrations of alpha synuclein seeds in blood serum may enable quicker diagnosis of neurodegenerative disorders.
May 30, 2023
Asep Medical Holdings aims for Nasdaq listing
Sepset Biosciences, an Asep Medical business, is preparing for clinical studies aimed at the commercialization of a diagnostic test. The test leverages gene expression to predict the development of severe sepsis.
May 31, 2023
Georgia doctor, clinics to pay $625K to resolve False Claims Act allegations
The defendants allegedly submitted improper claims to Medicare and Tricare insurance programs for evaluation and management services as well as medically unnecessary urine drug screening tests.
May 31, 2023
Romanian IVD market worth watching, rose to $464M in 2022
The Eastern European country's IVD market will grow 25% faster than that of the United States, according to Kalorama Information in its latest 30-Country IVD Market Atlas.
May 31, 2023
Single-cell RNA sequencing data reveals T cells linked to cancer immunotherapy resistance
Scientists at the University of Texas MD Anderson Cancer Center have provided a new explanation for why checkpoint inhibitors are ineffective in some patients.
May 30, 2023
Bacteria vary between early- and late-onset colorectal cancer tumors: Study
Bacteria types vary widely between early- versus late-onset colorectal cancer tumors, providing clues to the disease’s increase in younger people, according to a study.
May 30, 2023
Blood biomarker in study predicts whether the cognitively healthy will develop Alzheimer’s
Astrocytes -- a subtype of glial cells that make up most cells in the human central nervous system -- may be the key driver of Alzheimer's disease progression, researchers said.
May 30, 2023
At ASCO meeting, Veracyte highlights prostate cancer study data using genomics database
The Decipher GRID database, which is used by Veracyte and its partners in urologic cancer research, comprises more than 100,000 whole-transcriptome profiles from patients with urologic cancers.
May 30, 2023
Lunit, Japan national cancer center collaborate on AI-based pathology for oncology
In collaborative studies with the national cancer center, researchers are evaluating the potential of the Lunit Scope artificial intelligence biomarker platform to predict clinical outcomes for rectal cancer.
May 30, 2023
